Evolution and prognosis of breast osteosarcoma: A case report

Guo,Wanfeng; Cao,Yang; Teng,Guangju; Liu,Jin; Su,Jianbin

doi:10.3892/ol.2015.3921

Evolution and prognosis of breast osteosarcoma: A case report

Authors:
- Wanfeng Guo
- Yang Cao
- Guangju Teng
- Jin Liu
- Jianbin Su
View Affiliations

Affiliations: Department of Health Care and Medicine, The Affiliated Hospital of the Chinese Academy of Military Medical Sciences, Beijing 100071, P.R. China, Department of Non‑Infectious Liver Disease, 302 Hospital of the People's Liberation Army, Beijing 100039, P.R. China
Published online on: November 16, 2015 https://doi.org/10.3892/ol.2015.3921
Pages: 789-791

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast osteosarcoma is a rare malignancy of unknown etiology, with no standard adjuvant treatment at present. The prognosis of the disease is poor, and it has a high propensity for recurrence and metastasis. The current report presents the case of a 52‑year‑old woman, in whom adenomyoepithelioma gradually developed into breast osteosarcoma following three separate surgeries. The patient survived for 41 months from the initial lesion occurrence and resection in the left breast; during this time, she underwent surgery and chemotherapy (liposomal doxorubicin and cisplatin) for the treatment of disease recurrence and lung metastasis, along with molecular‑targeted therapy (sunitinib). However, the patient eventually succumbed to respiratory failure due to progressive disease. The present case underwent a clear pathological transformation process, and may provide a basis for an improved understanding of the clinical characteristics and treatment of breast osteosarcoma.

View Figures

View References

1	Adem C, Reynolds C, Ingle JN and Nascimento AG: Primary breast sarcoma: Clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 91:237–241. 2004.PubMed/NCBI
2	Haberthür F, Feichter GE and Torhorst JK: Sarcoma of the breast: What is the contribution of immunohistochemistry and flow cytometry? Geburtshilfe Frauenheilkd. 53:811–813. 1993.(In German). View Article : Google Scholar : PubMed/NCBI
3	Krishnamurthy A: Primary breast osteosarcoma: A diagnostic challenge. Indian J Nucl Med. 30:39–41. 2015. View Article : Google Scholar : PubMed/NCBI
4	Jernstrom P, Lindberg AL and Meland ON: Osteogenic sarcoma of the mammary gland. Am J Clin Pathol. 40:5211963.PubMed/NCBI
5	Al Samaraee A, Angamuthu N and Fasih T: Primary breast osteosarcoma: A case report and review of literature. Scott Med J. 59:e1–e4. 2014. View Article : Google Scholar : PubMed/NCBI
6	Remadi S, Doussis-Anagnostopoulu I and MacGee W: Primary osteosarcoma of the breast. Pathol Res Pract. 191:471–474. 1995. View Article : Google Scholar : PubMed/NCBI
7	Silver SA and Tavassoli FA: Primary osteogenic sarcoma of the breast: A clinicopathologic analysis of 50 cases. Am J Surg Pathol. 22:925–933. 1998. View Article : Google Scholar : PubMed/NCBI
8	Jacobs TW, Gown AM, Yaziji H, Barnes MJ and Schnitt SJ: Comparison of fluorscence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol. 17:1974–1982. 1999.PubMed/NCBI
9	Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
10	Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 2006.http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf
11	Lagrange JL, Ramaioli A, Chateau MC, et al: Sarcoma after radiation therapy: Retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation therapist and pathologist groups of the Fédération Nationale des Centres de Lutte Contre le Cancer. Radiology. 216:197–205. 2000. View Article : Google Scholar : PubMed/NCBI
12	Nwankwo N, Barbaryan A, Ali AM, et al: Breast osteosarcoma 29 years after radiation therapy for epithelial breast cancer. Case Rep Oncol. 6:367–372. 2013. View Article : Google Scholar : PubMed/NCBI
13	Lum WY and Jacobs L: Primary breast sarcoma. Surg Clin North Am. 88:559–570. 2008. View Article : Google Scholar : PubMed/NCBI
14	Vorobiof G, Hariparsad G, Freinkel W, Said H and Vorobiof DA: Primary osteosarcoma of the breast: A case report. Breast J. 9:231–233. 2003. View Article : Google Scholar : PubMed/NCBI
15	Blanchard DK, Reynolds CA, Grant CS and Donohue JH: Primary nonphylloides breast sarcomas. Am J Surg. 186:359–361. 2003. View Article : Google Scholar : PubMed/NCBI
16	Zhao J, Zhang X, Liu J and Li J: Primary osteosarcoma of the breast with abundant chondroid matrix and fibroblasts has a good prognosis: A case report and review of the literature. Oncol Lett. 6:745–747. 2013.PubMed/NCBI
17	Szajewski M, Kruszewski WJ, Ciesielski M, et al: Primary osteosarcoma of the breast: A case report. Oncol Lett. 7:1962–1964. 2014.PubMed/NCBI
18	Cassier PA, Dufresne A, Fayette J, et al: Emerging drugs for the treatment of soft tissue sarcomas. Expert Opin Emerg Drugs. 12:139–153. 2007. View Article : Google Scholar : PubMed/NCBI
19	Shor AC, Agresta SV, D'Amato GZ and Sondak VK: Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas. Cancer Control. 15:47–54. 2008.PubMed/NCBI